This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Humana (HUM) Extends Ties for Automating Prior Authorizations
by Zacks Equity Research
Humana (HUM) expands partnership with Epic in a bid to offer electronic prior authorizations, member insights and other capabilities for patients and providers.
4 Stocks That Continue to Gain From Telehealth Offerings
by Zacks Equity Research
We take a sneak peek into four telehealth stocks that are well-poised for growth on their robust digital services suite.
UnitedHealthcare (UNH) Expands Virtual Care to Hearing Aids
by Zacks Equity Research
UnitedHealthcare's (UNH) new virtual care model Right2You aims to provide its members with an online service for custom-programed hearing aids.
Humana (HUM) Puts Senior-Focused Centers Under CenterWell Brand
by Zacks Equity Research
Humana (HUM) unveils the CenterWell brand, which will bring together the company's senior-focused primary care centers in a bid to offer personalized health care plans for senior patients.
Top Analyst Reports for Microsoft, Caterpillar & Target
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Caterpillar (CAT), and Target (TGT).
UnitedHealth (UNH) Invests in Technology to Lead the Industry
by Zacks Equity Research
The breakout of COVID-19 fuels the use of technology in the healthcare space and UnitedHealth (UNH) is promptly acting on this to ramp up its technological innovations.
7 Multiline Insurers to Watch Out For as COVID-Led Challenges Ease
by Tanuka De
Better pricing, product redesigns and increased adoption of technology are expected to aid multiline insurers like CI, ORI, JRVR, HIG, PRU, AIG and MET. However, a low-rate environment remains a headwind.
Why Is Cigna (CI) Up 12.3% Since Last Earnings Report?
by Zacks Equity Research
Cigna (CI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Humana (HUM) Unit Expands to Meet Senior-Focused Health Needs
by Zacks Equity Research
Humana's (HUM) subsidiary Conviva acquires a primary care physician network in South Florida for boosting healthcare services offered to seniors across the region.
Cigna (CI) Set to Expand in Telehealth Via MDLIVE Buyout
by Zacks Equity Research
Cigna (CI) is set to buy MDLIVE, a provider of telehealth services, to gain share in the growing market.
Humana (HUM), Mercy Tie Up to Extend Telehealth Services
by Zacks Equity Research
Humana (HUM) partners with Mercy to expand virtual care services for members.
Humana (HUM) to Offer Integrated Care to Specific MA Members
by Zacks Equity Research
Humana (HUM) unveils Humana Care Support driven by data and analytics in a bid to offer personalized care to a selected group of Medicare Advantage members.
Top Analyst Reports for Amazon, Royal Dutch Shell & Estee Lauder
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), Royal Dutch Shell (RDS.A), and Estee Lauder (EL).
Cigna (CI) Q4 Earnings Miss, Decline Y/Y on Elevated Claims
by Zacks Equity Research
Cigna's (CI) Q4 results reflect higher revenues, partly offset by an increase in COVID-related claims that eroded its bottom line.
Cigna (CI) Q4 Earnings Miss Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of -4.10% and 4.17%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Cigna's (CI) fourth-quarter results are likely to reflect strong performance across the business portfolio and lower SG&A costs, partly offset by continued COVID-19 related expenses.
Will Intercontinental Exchange (ICE) Q4 Earnings Top Estimates?
by Zacks Equity Research
Intercontinental Exchange (ICE) Q4 result is likely to benefit from diversified asset class, balanced mix of recurring and transaction-based revenues and market volatility.
Unum Group (UNM) Q4 Earnings Coming Up: What's in Store?
by Zacks Equity Research
Unum Group's (UNM) Q4 results are likely to reflect soft performance at Unum U.S. and Colonial Life segments.
What's in Store for Prudential (PRU) This Earnings Season?
by Zacks Equity Research
Prudential's (PRU) Q4 results are likely to reflect fixed income inflows, solid investment performance and higher reserve gains.
Cigna (CI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why is it Advisable to Hold on to Cigna (CI) Stock Now?
by Zacks Equity Research
Cigna (CI) looks poised to grow on the back of business rejig, which involves growing its healthcare business while lowering debt.
Why Cigna (CI) Could Beat Earnings Estimates Again
by Zacks Equity Research
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cigna (CI) to Gain From Integrated Benefits & Lower Costs
by Zacks Equity Research
Cigna (CI) reinforces the importance of integrated benefits, which has been reducing healthcare costs and resulting in improved health conditions.
4 HMO Stocks in Focus as Players Adapt to Changes in the Industry
by Zacks Equity Research
Changing political scenario, increased investments in technology, growing senior population carve a strong growth trajectory for players in the HMO industry.
Cigna (CI) Extends MA Network With Iora for Better Healthcare
by Zacks Equity Research
Cigna's (CI) MA network expands with the inclusion of Iora Health. The move intends to provide improved health outcomes for seniors.